Hypothesis

We hypothesize that the circadian clock protects beta cells not by constantly elevating proteostatic capacity but by imposing a precise temporal offset between UPR activation and autophagy flux. This offset creates a daily window where misfolded IAPP is cleared before it can seed amyloid. Disruption of this offset—through genetic clock loss or environmental chronodisruption—causes UPR and autophagy to become either simultaneously active or simultaneously inactive, permitting IAPP oligomers to accumulate and spread.

Mechanistic Rationale

BMAL1/CLOCK drives rhythmic transcription of UPR chaperones (BiP, CHOP) and autophagy genes (LC3, p62) [1]. However, BMAL1 also represses mTORC1, which inhibits autophagy [3]. In a healthy clock, the peak of UPR expression precedes the trough of mTORC1 activity, yielding a phase‑shifted autophagy surge that degrades ubiquitinated IAPP. When BMAL1 is arrhythmic, UPR and mTORC1 oscillate in phase, collapsing the protective offset and leaving nascent IAPP oligomers uncleared.

This model explains why BMAL1 deletion can both increase basal autophagy [4] and heighten ER stress [1]: the loss of timing uncouples synthesis from degradation, turning a potentially protective autophagy response into a futile cycle that fails to keep up with IAPP load.

Testable Predictions

1. Phase relationship: In isolated mouse islets, the peak of BiP mRNA will occur ~4‑6 h before the peak of LC3‑II lipidation under normal light‑dark cycles; this interval will shorten or invert in Bmal1‑KO or constant‑light conditions.
2. IAPP seeding: Inducing a phase‑misaligned UPR (e.g., timed tunicamycin administration) will increase extracellular IAPP oligomer secretion by >2‑fold compared with aligned stress, measurable by seed‑competent assays.
3. Rescue by timed melatonin: Administering melatonin at the subjective dusk (when BMAL1 rises) will restore the UPR‑autophagy offset in disrupted islets and reduce IAPP‑positive area by ≥30 % after 4 weeks of high‑fat diet feeding.
4. mTORC1 timing: Phospho‑S6K (mTORC1 readout) will peak opposite to LC3‑II in wild‑type islets; clock disruption will align these peaks, correlating with elevated p‑eIF2α and CHOP.

Experimental Approach

• Islet culture: Harvest islets from WT and Bmal1‑fl/fl;Ins1‑Cre mice. Synchronize with dexamethasone shock, then collect samples every 4 h for 24 h. Perform qPCR for BiP, CHOP, LC3, p62; Western blot for LC3‑II, phospho‑S6K, phospho‑eIF2α.
• IAPP seeding assay: Treat islets with recombinant human IAPP fibrils at circadian time 0 or 12. Measure intracellular oligomer levels by FRET‑based sensor and extracellular seeding activity using a biosensor cell line.
• In vivo rescue: Feed WT and Bmal1‑KO mice high‑fat diet ± melatonin (0.1 mg/kg) administered via drinking water restricted to ZT12‑ZT0. After 12 weeks, quantify IAPP deposition by immunohistochemistry, β‑cell mass, and glucose tolerance.
• Pharmacological test: Use rapamycin (mTORC1 inhibitor) administered at specific circadian times to test whether forcing an autophagy window can compensate for clock loss.

Falsifiability

If experiments show that UPR and autophagy peak synchronously in healthy islets, or that restoring their phase offset fails to reduce IAPP amyloid despite normalized expression levels, the hypothesis would be refuted. Conversely, observing a consistent phase gap that predicts resistance to seeding, and its loss predicting susceptibility, would support the model.

This reframes the circadian firewall as a timing‑sensitive coupling mechanism rather than a static boost, offering a chronotherapeutic angle for preventing beta‑cell failure in type 2 diabetes.